[Skip to Content]
[Skip to Content Landing]
Views 94
Citations 0
Comment & Response
April 2018

Methodological and Efficacy Issues in a Randomized Clinical Trial Investigating Vitreous Floater Treatment

Author Affiliations
  • 1VMR Institute for Vitreous Macula Retina, Huntington Beach, California
JAMA Ophthalmol. 2018;136(4):448. doi:10.1001/jamaophthalmol.2018.0212

To the Editor The negative impact of vitreous floaters is becoming increasingly apparent.1 Clinically relevant cases with abnormal vitreous structure and degraded contrast sensitivity function can be called vision-degrading vitreopathy to distinguish from insignificant cases. Increasingly, patients with this condition are being offered therapy by various means.

First Page Preview View Large
First page PDF preview
First page PDF preview
×